Tumorigenic pathways in low‐stage bladder cancer based on p53, MDM2 and p21 phenotypes
暂无分享,去创建一个
François G. Meyer | L. Lacombe | B. Têtu | L. Moore | F. Meyer | Y. Fradet | H. Larue | C. Pfister | C. Veilleux | B. Têtu
暂无分享,去创建一个
François G. Meyer | L. Lacombe | B. Têtu | L. Moore | F. Meyer | Y. Fradet | H. Larue | C. Pfister | C. Veilleux | B. Têtu